BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9627653)

  • 21. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cat scratch disease: posterior segment manifestations.
    Solley WA; Martin DF; Newman NJ; King R; Callanan DG; Zacchei T; Wallace RT; Parks DJ; Bridges W; Sternberg P
    Ophthalmology; 1999 Aug; 106(8):1546-53. PubMed ID: 10442903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
    Harrison JM; van Heuven WA
    Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular toxoplasmosis: clinical characteristics in pediatric patients.
    Garza-Leon M; Garcia LA
    Ocul Immunol Inflamm; 2012 Apr; 20(2):130-8. PubMed ID: 22409567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Ocular Toxoplasmosis Presenting to Uveitis Services in a Non-endemic Setting.
    Bhikoo R; Damato EM; Guest S; Sims J
    Korean J Ophthalmol; 2019 Dec; 33(6):514-519. PubMed ID: 31833248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates.
    Vasconcelos-Santos DV; Machado Azevedo DO; Campos WR; Oréfice F; Queiroz-Andrade GM; Carellos EV; Castro Romanelli RM; Januário JN; Resende LM; Martins-Filho OA; de Aguiar Vasconcelos Carneiro AC; Almeida Vitor RW; Caiaffa WT;
    Ophthalmology; 2009 Nov; 116(11):2199-205.e1. PubMed ID: 19744724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryotreatment of toxoplasmosis retinochoroiditis.
    Jacklin HN
    Ann Ophthalmol; 1975 Jun; 7(6):853-5. PubMed ID: 1147513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ocular toxoplasmosis presenting as neuroretinitis: report of two cases.
    Küçükerdönmez C; Akova YA; Yilmaz G
    Ocul Immunol Inflamm; 2002 Sep; 10(3):229-34. PubMed ID: 12789599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical profile, treatment, and visual outcome of serpiginous choroiditis.
    Abrez H; Biswas J; Sudharshan S
    Ocul Immunol Inflamm; 2007; 15(4):325-35. PubMed ID: 17763131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and prognosis in ocular toxoplasmosis.
    Atmaca LS; Simsek T; Batioglu F
    Jpn J Ophthalmol; 2004; 48(4):386-91. PubMed ID: 15295668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ocular toxoplasmosis: clinical features and prognosis of 154 patients.
    Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A
    Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular manifestations associated with chikungunya.
    Mahendradas P; Ranganna SK; Shetty R; Balu R; Narayana KM; Babu RB; Shetty BK
    Ophthalmology; 2008 Feb; 115(2):287-91. PubMed ID: 17631967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoplasmosis.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):129-41. PubMed ID: 16282146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "I think we have a problem in Victoria": MDs respond quickly to toxoplasmosis outbreak in BC.
    Mullens A
    CMAJ; 1996 Jun; 154(11):1721-4. PubMed ID: 8646660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis.
    Delair E; Monnet D; Grabar S; Dupouy-Camet J; Yera H; Brézin AP
    Am J Ophthalmol; 2008 Dec; 146(6):851-5. PubMed ID: 18723143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytologic identification of Toxoplasma gondii from vitreous fluid.
    Greven CM; Teot LA
    Arch Ophthalmol; 1994 Aug; 112(8):1086-8. PubMed ID: 8053823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presumed ocular toxoplasmosis: some clinical observations.
    Williams TD
    Am J Optom Physiol Opt; 1979 Oct; 56(10):633-41. PubMed ID: 525667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic benefits of infrared (810-nm) diode laser macular grid photocoagulation in prophylactic treatment of nonexudative age-related macular degeneration: two-year results of a randomized pilot study.
    Olk RJ; Friberg TR; Stickney KL; Akduman L; Wong KL; Chen MC; Levy MH; Garcia CA; Morse LS
    Ophthalmology; 1999 Nov; 106(11):2082-90. PubMed ID: 10571341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.